Avoid common mistakes on your manuscript.
Introduction
Tumors of the lacrimal gland are rare, with an incidence of less than 1 per 1,000,000 individuals per year [1]. They represent 6–12% of all orbital space-occupying lesions. Approximately 22–28% of these are primary epithelial tumors [2,3,4].
Since lacrimal gland tumors generally recapitulate the clinicopathologic features of their salivary gland counterparts, the World Health Organization (WHO) classification of salivary gland tumors can be applied to these tumors as well [5].
Fifty percent of primary epithelial tumors of the lacrimal gland are malignant. The most frequently encountered type is adenoid cystic carcinoma, which comprises approximately 20–30% of malignant neoplasms [6]. However, a variety of malignant tumor types that mirror their salivary gland counterparts have been described including ductal carcinoma, acinic cell carcinoma, primary squamous cell carcinoma, mucoepidermoid carcinoma, oncocytic carcinoma, polymorphous low-grade adenocarcinoma, carcinoma ex pleomorphic adenoma, myoepithelial carcinoma, lymphoepithelial carcinoma, epithelial-myoepithelial carcinoma, cystadenocarcinoma, primary sebaceous adenocarcinoma, and basal cell adenocarcinoma.
On the other hand, the most common benign tumor is pleomorphic adenoma, which comprises around 50% of all epithelial tumors [3, 4]. Other benign salivary type tumors that have been described in lacrimal gland are exceptionally rare [7] and include oncocytoma, cystadenoma, myoepithelioma, and Warthin tumor, also known as papillary cystadenoma lymphomatosum.
Here, we present, to our knowledge, the first description of a case of non-sebaceous lymphadenoma of the lacrimal gland.
Case report
In June 2015, a female, 62-year-old patient underwent a computed tomography (CT) scan of the brain due to an episode of syncope. As an incidental finding, the scan showed a 20 × 13 × 22-mm tumor in the orbital pole of the left lacrimal gland (Fig. 1). The patient was referred to the Department of Ophthalmology of our institution for further evaluation. The clinical examination showed a 3-mm exophthalmos with a 2-mm downward dislocation of the left eyeball, and magnetic resonance imaging (MRI) performed in September 2015 confirmed the initial CT findings.
Although there was no radiologic evidence of progression, the patient complained of increasing pain in the left orbital and temporal region and was referred to the Department of Oral and Maxillofacial Surgery for removal of the mass via lateral orbitotomy. The tumor was removed en-bloc, including the attached periorbit and a cuff of orbital fat.
The tumor was sharply demarcated with a tan cut surface, 1.5 cm in diameter (Fig. 2). No cystic areas were noted grossly or histologically. Microscopically, the tumor demonstrated prominent lymphoid stroma, with scattered germinal centers, and an epithelial component consisting of solid cords and trabeculae, with occasional tubuloglandular structures composed predominantly of basal and low columnar cells (Fig. 2). Tumor cells demonstrated very little atypia, and mitoses were rare. The Ki67 proliferation index was below 2%. Normal adipose tissue and lacrimal gland were noted at the periphery of the tumor capsule. Surgical resection margins were negative. Immunohistochemically, the basal (abluminal) tumor cells demonstrated a clear and strong nuclear reaction with the p63 antibody (Fig. 2), while cytokeratin 7 was positive in luminal cells (Fig. 2). Myoepithelial markers such as calponin and smooth muscle actin were negative, as well as SOX10, p16, and PCR for human papilloma virus (HPV) and Epstein-Barr virus (EBV)-encoded small RNAs. Based on the morphological and immunohistochemical findings, a diagnosis of non-sebaceous lymphadenoma was made.
The postoperative course was uneventful and the patient was discharged 5 days after the operation. A CT scan after 6 months showed no sign of recurrence and the scar was barely visible. The patient is now undergoing routine surveillance.
Discussion
Lymphadenomas are rare benign tumors of the major salivary glands, comprising a biphasic tumor cell population that exhibit groups of epithelial cells with or without sebaceous differentiation admixed with intense, reactive lymphoid proliferation. The clinicopathological features of lymphadenomas are poorly understood and their etiology is unknown. Less than 110 cases have been published since they were first described in 1960 [8].
Lymphadenomas typically occur in adults and usually present as a painless mass of long duration in the parotid gland. They are currently subdivided into sebaceous and non-sebaceous lymphadenomas. Non-sebaceous lymphadenomas are less common constituting only 1/3 of all reported cases [8, 9].
The pathogenesis of non-sebaceous lymphadenoma is poorly understood. The lymphoid component in particular is a subject of debate. Many authors regard the lymphoid component as reactive tumor-associated lymphoid tissue [10, 11] while other authors argue that the lymphoid stroma originates from intraparotid lymph nodes, with the epithelial component originating from salivary gland inclusions [12, 13].
In the present case, there were no histologic features (i.e., subcapsular sinuses) to suggest a pre-existing lymph node. Additionally, lacrimal glands do not generally contain intraglandular lymph nodes, making the nodal hypothesis less plausible, at least in this case. This description of a non-sebaceous lymphadenoma in the lacrimal gland does however further substantiate the validity of applying a similar classification scheme for both lacrimal gland and salivary gland tumors [14].
Differential diagnostic considerations for non-sebaceous lymphadenoma include other salivary tumors with prominent lymphoid stroma, such as mucoepidermoid carcinoma, Warthin’s tumor, and acinic cell carcinoma, as well as metastatic non-keratinizing squamous cell carcinoma or lymphoepithelial carcinoma, either HPV- or EBV-driven. The basaloid nested appearance argues against the aforementioned other tumor types. The absence of atypia, necrosis, and high mitotic counts, and negativity for HPV and EBV argue against a metastatic non-keratinizing squamous cell carcinoma or lymphoepithelial carcinoma.
Since 1991, to the best of our knowledge, only 53 cases of non-sebaceous lymphadenoma of the salivary glands have been reported in the literature [8, 10,11,12,13, 15].
In contrast to sebaceous lymphadenomas, non-sebaceous lymphadenomas are more common in women than in men. All non-sebaceous lymphadenomas involved the salivary glands but, in comparison with sebaceous lymphadenomas, extraparotid localization was evident in 40% of these patients (sebaceous lymphadenomas were intraparotid in nearly 90% of patients). No other demographic, clinical, or pathologic differences are known between these two subtypes. While follow-up data are limited, non-sebaceous lymphadenomas appear to be indolent tumors. Though rare cases of sebaceous lymphadenoma have been reported to undergo malignant transformation, this has not yet been described in non-sebaceous lymphadenoma [12].
We presented a case of a non-sebaceous lymphadenoma of the lacrimal gland, which, to the best of our knowledge, is the first report of such case in the medical literature. Our patient is symptom- and tumor-free more than 2 years after the initial presentation and surgery.
References
von Holstein SL, Therkildsen MH, Prause JU, Stenman G, Siersma VD, Heegaard S (2013) Lacrimal gland lesions in Denmark between 1974 and 2007. Acta Ophthalmol 91:349–354
Kennedy RE (1984) An evaluation of 820 orbital cases. Trans Am Ophthalmol Soc 82:134–157
Shields CL, Shields JA, Eagle RC, Rathmell JP (1989) Clinicopathologic review of 142 cases of lacrimal gland lesions. Ophthalmology 96:431–435
Johansen S, Heegaard S, Bogeskov L, Prause JU (2000) Orbital space-occupying lesions in Denmark 1974–1997. Acta Ophthalmol Scand 78:547–552
(2017) Tumours of salivary glands In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO classification of head and neck tumours, 4th edn. IARC, Lyon, pp 159–201
von Holstein SL, Coupland SE, Briscoe D, Le Tourneau C, Heegaard S (2013) Epithelial tumours of the lacrimal gland: a clinical, histopathological, surgical and oncological survey. Acta Ophthalmol 91:195–206
Font RL, Croxatto JO, Rao NA (2006) Tumours of the lacrimal gland. In: Silverberg SG (ed) Tumours of the eye and ocular adnexa, 4th edn. American Registry of Pathology / Armed Forces Institute of Pathology, Washington DC, pp 223–246
Liu G, He J, Zhang C, Fu S, He Y (2014) Lymphadenoma of the salivary gland: report of 10 cases. Oncol Lett 7:1097–1101
(2017) Tumours of salivary glands. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO classification of head and neck tumours, 4th edn. IARC, Lyon, pp 190–191
Yang S, Chen X, Wang L, Zhang J (2007) Non-sebaceous lymphadenoma of the salivary gland: case report with immunohistochemical investigation. Virchows Arch 450:595–599
Gallego L, Junquera L, Fresno MF (2009) Non-sebaceous lymphadenoma of the parotid gland: immunohistochemical study and DNA ploidy analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:555–558
Seethala RR, Thompson LDR, Gnepp DR, Barnes EL, Skalova A, Montone K, Kane S, Lewis JS Jr, Solomon LW, Simpson RHW, Khan A, Prasad ML (2012) Lymphadenoma of the salivary gland: clinicopathological and immunohistochemical analysis of 33 tumors. Mod Pathol 25:26–35
Weiler C, Agaimy A, Zengel P, Zenk J, Kirchner T, Ihrler S (2012) Nonsebaceous lymphadenoma of salivary glands: proposed development from intraparotid lymph nodes and risk of misdiagnosis. Virchows Arch 460:467–472
Weis E, Rootman J, Joly TJ, Berean KW, Al-Katan HM, Pasternak S, Bonavolontà G, Strianese D, Saeed P, Feldman KA, Vangveeravong S, Lapointe JS, White VA (2009) Epithelial lacrimal gland tumors pathologic classification and current understanding. Arch Ophthalmol 127:1016–1028
Musthyala NB, Low SE, Seneviratne RH (2009) Lymphadenoma of the salivary gland: a rare tumour. J Clin Pathol 57:1007
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This manuscript is a report of a case with a review of the literature. Research work with human and animal subjects was not conducted in preparation of this manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Pau, M., Brcic, L., Seethala, R.R. et al. Non-sebaceous lymphadenoma of the lacrimal gland: first report of a new localization. Virchows Arch 473, 127–130 (2018). https://doi.org/10.1007/s00428-018-2322-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-018-2322-4